
Graduate in Medicine and Surgery from the University of Valencia in 1993, with subsequent specialization in Gynecology and Obstetrics at the La Fe University Hospital in Valencia in 1998. Awarded a Doctorate in Medicine and Surgery from the Universitat de València in 2002, with a thesis titled "Vertical Transmission of HIV." Possesses extensive experience in biostatistics following the completion of the Statistical Methods in Health Sciences course at the Laboratory of Applied and Modeling Statistics, Autonomous University of Barcelona in 1995.
Currently a member of the Benign Gynecology Pathology Unit and the Functional Breast Unit at Bellvitge University Hospital and she serves as the supervisor for residents in the department. Since 2014, she has been an associate professor at the University of Barcelona, accredited by the AQU since 2019. In recent years, she has focused on the development of gynecological intervention guided by ultrasound for the puncture and sclerosis of low-risk ovarian cysts.
In terms of research, Dr. Garcia has participated in numerous national and international trials, notably serving as the principal investigator (PI) in a multicenter study titled "Evaluation of Ovarian Reserve After Treatment of Endometriomas by Sclerosis with Alcohol or Surgery Using Anti-Müllerian Hormone." This study is funded by the Carlos III Health Institute. It is worth mentioning that she also leads as PI a study on Radiofrequency Ablation of early-stage breast tumors. Another study focuses on reducing affected margins in conservative surgery for breast cancer, while another aims to validate selective axillary dissection (TAD) after neoadjuvant chemotherapy in locally advanced axillary breast cancer (N2) patients. Finally, her leadership in the multicenter study known as ADARNAT, comparing axillary lymphadenectomy to axillary radiotherapy in patients with positive sentinel nodes after neoadjuvant therapy, is noteworthy. This study is a randomized phase III multicenter trial.
Selected publications from PubMed

Graduate in Medicine and Surgery from the University of Valencia in 1993, with subsequent specialization in Gynecology and Obstetrics at the La Fe University Hospital in Valencia in 1998. Awarded a Doctorate in Medicine and Surgery from the Universitat de València in 2002, with a thesis titled "Vertical Transmission of HIV." Possesses extensive experience in biostatistics following the completion of the Statistical Methods in Health Sciences course at the Laboratory of Applied and Modeling Statistics, Autonomous University of Barcelona in 1995. Currently a member of the Benign Gynecology Pathology Unit and the Functional Breast Unit at Bellvitge University Hospital and she serves as the supervisor for residents in the department. Since 2014, she has been an associate professor at the University of Barcelona, accredited by the AQU since 2019. In recent years, she has focused on the development of gynecological intervention guided by ultrasound for the puncture and sclerosis of low-risk ovarian cysts. In terms of research, Dr. Garcia has participated in numerous national and international trials, notably serving as the principal investigator (PI) in a multicenter study titled "Evaluation of Ovarian Reserve After Treatment of Endometriomas by Sclerosis with Alcohol or Surgery Using Anti-Müllerian Hormone." This study is funded by the Carlos III Health Institute. It is worth mentioning that she also leads as PI a study on Radiofrequency Ablation of early-stage breast tumors. Another study focuses on reducing affected margins in conservative surgery for breast cancer, while another aims to validate selective axillary dissection (TAD) after neoadjuvant chemotherapy in locally advanced axillary breast cancer (N2) patients. Finally, her leadership in the multicenter study known as ADARNAT, comparing axillary lymphadenectomy to axillary radiotherapy in patients with positive sentinel nodes after neoadjuvant therapy, is noteworthy. This study is a randomized phase III multicenter trial.
With Bellvitge Alumni of Gynaecology Academy
Published
Dec 2024

Since the description of the first vaginal hysterectomy in 1813, the surgical technique has experienced minor advancements compared to the associated technology for the same procedure. These advancements allow us to perform this surgery in a more precise, efficient, and safe manner for patients. Despite a slight trend towards a reduction in its performance, in the United States, it remains the most frequent surgery among the female population. That is why it requires proper learning and standardization of surgical steps, which we will explain in detail. Not only that, but we will also teach different techniques for the same surgical step, which will provide us with additional surgical resources to apply in a more personalized manner. This lecture is recommended, from surgeons in training who can familiarize themselves with the anatomical spaces,, to advanced surgeons who may find certain surgical maneuvers performed using robotic surgery interesting.
With Bellvitge Alumni of Gynaecology Academy
Published
Jul 2023
Help your network discover Dr. Amparo García-Tejedor's clinical expertise.